Distribution of HIV drugs in poor countries stopped
On Friday, a memorandum signed by Marco Rubio called for a 90-day cessation of foreign aid. That would likely put on hold the work of PEPFAR, the President's Emergency Plan for AIDS Relief.
The President's Emergency Plan for AIDS Relief, or PEPFAR, provides billions in funding to organizations to combat HIV.
The President’s Emergency Plan for AIDS Relief, or PEPFAR, is credited with saving 25 million lives worldwide and has long enjoyed bipartisan support.
US President Donald Trump recently announced a freeze on an emergency plan for AIDS relief, also known as the President's Emergency Plan for AIDS Relief.
The Trump administration has issued a waiver to ensure uninterrupted HIV treatment for 20 million people in 55 countries, despite a 90-day freeze on U.S. foreign aidGlobal health leaders, including UNAIDS Executive Director Winnie Byanyima,
The World Health Organisation (WHO) has expressed deep concern about the funding pause for HIV programmes in low- and middle-income countries.
Secretary of State Marco Rubio’s order to pause nearly all foreign aid has halted funding to the President’s Emergency Plan for AIDS Relief (PEPFAR), an African HIV-prevention program launched by President George W. Bush in 2003 that has saved over 25 million lives.
The Democratic Alliance (DA) and Build One South Africa (Bosa) have expressed concern over the US government’s decision to suspend over $400 million (R7.4 billion) in Pepfar (US President’s Emergency Plan for Aids Relief) funding for HIV/Aids programs in South Africa.
The federal government has commended the United States for approving an ‘emergency humanitarian waiver’ that allows HIV treatment funded by the US government across 55 countries, including Nigeria.
The United States has approved an emergency humanitarian waiver allowing continued access to HIV treatment funded by the U.S. across 55 countries worldwide including Kenya. On January 29, 2025, U.S. Secretary of State Marco Rubio authorized the waiver,
PEPFAR, a $7.5 billion initiative established in 2003, has provided HIV care to millions worldwide. The recent suspension of the program raised concerns about the potential loss of access to HIV medications for more than 20 million people.